Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions? - Poll - MDSpire

Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?

  • By

  • Daniel Rivas

  • Alejandro de la Torre-Luque

  • Elena Moreno-Olmedo

  • Paloma Moreno

  • Vladimir Suárez

  • Ana Serradilla

  • Gregorio Arregui

  • David Álvarez

  • Morena Sallabanda

  • Antonio Lazo

  • María Isabel Núñez

  • Escarlata López

  • July 24, 2024

  • 0 min

Share

Original Source(s)

Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?

  • by Daniel Rivas, Alejandro de la Torre-Luque, Elena Moreno-Olmedo, Paloma Moreno, Vladimir Suárez, Ana Serradilla, Gregorio Arregui, David Álvarez, Morena Sallabanda, Antonio Lazo, María Isabel Núñez, Escarlata López

  • July 24, 2024

Related Content

Prostate Cancer Conference Highlights from ASCO GU 2025

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from GU ASCO 2025. This video highlights updates in mCRPC and oligometastatic prostate cancer trials.

  • March 3, 2025

  • 1 min
Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis

Evaluating the Role of PSMA-PET in Enhancing Salvage Radiotherapy: A Discussion on Precision versus Timing